JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
SNEX
StoneX Group Inc.
SNEX has the edge over JPM overall, supported by stronger fundamentals and stronger modeled upside.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SNEX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
SNEX's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like SNEX.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over SNEX in the historical PE scenario, which offers more potential upside but is not a forecast.
SNEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $33.61 | -41% |
| Fair | 10x | $43.51 | -24% |
| Forward | 13x | $57.11 | — |
| Current | 14x | $57.11 | — |
| Expensive | 15x | $64.87 | +14% |
Historical ranges are pointers, not guarantees.
SNEX's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
SNEX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
SNEX has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
SNEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.42 | +5.6% |
| Q2 2026 | $4.19 | +61% |
| Q1 2026 | $3.73 | +42% |
| Q4 2025 | $2.98 | +20% |
| Q3 2025 | $2.62 | +11% |
| Q2 2025 | $2.61 | +22% |
| Q1 2025 | $2.62 | +18% |
| Q4 2024 | $2.48 | +17% |
| Q3 2024 | $2.36 | +6.8% |
SNEX has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over SNEX on profitability, with a higher operating margin.
SNEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $719.7M | +47% |
| Q1 2026 | $829.1M | +70% |
| Q4 2025 | $724.4M | +47% |
| Q3 2025 | $585.1M | +29% |
| Q2 2025 | $488.3M | +4.2% |
| Q1 2025 | $487.3M | +15% |
| Q4 2024 | $492.1M | +17% |
| Q3 2024 | $454.8M | +13% |
SNEX has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 22% | +24 points |
| Q1 2026 | 27% | +29 points |
| Q4 2025 | 26% | +30 points |
| Q3 2025 | 19% | +21 points |
| Q2 2025 | -2.2% | +3.5 points |
| Q1 2025 | -1.8% | +1.3 points |
| Q4 2024 | -4.3% | -0.6 points |
| Q3 2024 | -2.1% | -21 points |
SNEX's operating margin was 22% last quarter, up 24 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
SNEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2B | -183% |
| Q1 2026 | $2.8B | +$2.9B |
| Q4 2025 | -$1.3B | -$785.5M |
| Q3 2025 | $3.5B | +1895% |
| Q2 2025 | $1.5B | +$2.1B |
| Q1 2025 | -$169.8M | -122% |
| Q4 2024 | -$491.4M | -452% |
| Q3 2024 | $175.9M | -51% |
SNEX has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over SNEX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
SNEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.9% | +2.3M shares |
| 1 year | +11% | +12.1M shares |
| 3 years | +19% | +19.9M shares |
| 5 years | +24% | +24M shares |
| Available history | +29% | +28.2M shares |
SNEX has 124M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2022 | — |
| Q3 2021 | $8.6M |
| Q2 2021 | $3.1M |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $7.1M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
SNEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -2.6x | Net Cash |
| Q4 2025 | -3.1x | Net Cash |
| Q3 2025 | -6.1x | Net Cash |
| Q2 2025 | -71.1x | Net Cash |
| Q2 2024 | -14.8x | Net Cash |
| Q1 2024 | -5.5x | Net Cash |
| Q4 2023 | -1.5x | Net Cash |
SNEX has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SNEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.2 | Neutral |
| Stochastic | 11.8 | Oversold |
SNEX's weekly RSI is 41 (neutral) and its Stochastic is 12 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
SNEX PE vs Financial Services Sector
| Metric | SNEX | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 4.8% above |
| PE % | 76 | 63 | 13 pts above |
SNEX has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over SNEX on trend strength, trading above more of its moving averages.
SNEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.0 | 3.2% below |
| 20 week MA | $66.4 | 14% below |
| 50 week MA | $62.7 | 8.8% below |
| 100 week MA | $50.4 | 13% above |
| 200 week MA | $35.6 | 60% above |
SNEX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 60% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
SNEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.59 | $11.2 | +17% |
| 2021 | $11.2 | $12.1 | +7.7% |
| 2022 | $12.1 | $19.1 | +58% |
| 2023 | $19.1 | $21.9 | +15% |
| 2024 | $21.9 | $29.4 | +34% |
| 2025 | $29.4 | $44.5 | +52% |
| 2026 YTD | $44.5 | $57.1 | +28% |
SNEX has the edge over JPM on returns for 2026, with the stronger performance.